Glucocorticoid Therapy and the Risk of Infection in Patients With Newly Diagnosed Autoimmune Disease.

MLA

Migita, Kiyoshi, et al. “Glucocorticoid Therapy and the Risk of Infection in Patients With Newly Diagnosed Autoimmune Disease.” Medicine, vol. 92, no. 5, Sept. 2013, pp. 285–93. EBSCOhost, https://doi.org/10.1097/MD.0b013e3182a72299.

APA

Migita, K., Sasaki, Y., Ishizuka, N., Arai, T., Kiyokawa, T., Suematsu, E., Yoshimura, M., Kawabe, Y., Matsumura, R., Akagawa, S., Mori, S., Shirai, M., Watanabe, Y., Minami, N., Soga, T., Owan, I., Ohshima, S., Yoshizawa, S., Matsui, T., … Bito, S. (2013). Glucocorticoid Therapy and the Risk of Infection in Patients With Newly Diagnosed Autoimmune Disease. Medicine, 92(5), 285–293. https://doi.org/10.1097/MD.0b013e3182a72299

Chicago

Migita, Kiyoshi, Yasuharu Sasaki, Naoki Ishizuka, Toru Arai, Tetsuyuki Kiyokawa, Eiichi Suematsu, Mitsuhiro Yoshimura, et al. 2013. “Glucocorticoid Therapy and the Risk of Infection in Patients With Newly Diagnosed Autoimmune Disease.” Medicine 92 (5): 285–93. doi:10.1097/MD.0b013e3182a72299.